NIAID Banner Logo Image

Other Viruses Citation List: February 1 - February 14, 2013

Epstein-Barr Virus

1. Tricyclic Benzo[cd]azulenes Selectively Inhibit Activities of PIM Kinases and Restrict Growth of Epstein-Barr Virus-transformed Cells. Kiriazis, A., R.L. Vahakoski, N.M. Santio, R. Arnaudova, S.K. Eerola, E.M. Rainio, I.B. Aumuller, J. Yli-Kauhaluoma, and P.J. Koskinen. Plos One, 2013. 8(2): p. e55409; PMID[23405147].

[PubMed] OV_0201-021413.

Hepatitis B Virus

2. Ezetimibe Blocks Hepatitis B Virus Infection after Virus Uptake into Hepatocytes. Lucifora, J., K. Esser, and U. Protzer. Antiviral Research, 2013. 97(2): p. 195-197; PMID[23266293].

[PubMed] OV_0201-021413.

3. Controllable Inhibition of Hepatitis B Virus Replication by a DR1-targeting Short Hairpin RNA (shRNA) Expressed from a DOX-inducible Lentiviral Vector. Wang, W., H. Peng, J. Li, X. Zhao, F. Zhao, and K. Hu. Virus Genes, 2013. [Epub ahead of print]; PMID[23397077].

[PubMed] OV_0201-021413.

Hepatitis C Virus

4. Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase. Fenaux, M., S. Eng, S.A. Leavitt, Y.J. Lee, E.M. Mabery, Y. Tian, D. Byun, E. Canales, M.O. Clarke, E. Doerffler, S.E. Lazerwith, W. Lew, Q. Liu, M. Mertzman, P. Morganelli, L. Xu, H. Ye, J. Zhang, M. Matles, B.P. Murray, J. Mwangi, J. Zhang, A. Hashash, S.H. Krawczyk, A.M. Bidgood, T.C. Appleby, and W.J. Watkins. Antimicrobial Agents and Chemotherapy, 2013. 57(2): p. 804-810; PMID[23183437].

[PubMed] OV_0201-021413.


5. Myriberine A, a New Alkaloid with an Unprecedented Heteropentacyclic Skeleton from Myrioneuron faberi. Huang, S.D., Y. Zhang, M.M. Cao, Y.T. Di, G.H. Tang, Z.G. Peng, J.D. Jiang, H.P. He, and X.J. Hao. Organic Letters, 2013. 15(3): p. 590-593; PMID[23320525].

[PubMed] OV_0201-021413.


6. Resistance Studies of a Dithiazol Analogue, DBPR110, as a Potential Hepatitis C Virus NS5A Inhibitor in Replicon Systems. Lin, H.M., J.C. Wang, H.S. Hu, P.S. Wu, W.H. Wang, S.Y. Wu, C.C. Yang, T.K. Yeh, T.A. Hsu, W.T. Jiaang, Y.S. Chao, J.H. Chern, and A. Yueh. Antimicrobial Agents and Chemotherapy, 2013. 57(2): p. 723-733; PMID[23165461].

[PubMed] OV_0201-021413.


7. Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived from GB Virus A NS5A. Liu, X., Y. Huang, M. Cheng, L. Pan, Y. Si, G. Li, Y. Niu, L. Zhao, J. Zhao, X. Li, Y. Chen, and W. Yang. Journal of Virology, 2013. 87(3): p. 1649-1657; PMID[23175359].

[PubMed] OV_0201-021413.


8. HCV NS5A Replication Complex Inhibitors. Part 3: Discovery of Potent Analogs with Distinct Core Topologies. Lopez, O.D., V.N. Nguyen, D.R. St Laurent, M. Belema, M.H. Serrano-Wu, J.T. Goodrich, F. Yang, Y. Qiu, A.S. Ripka, P.T. Nower, L. Valera, M. Liu, D.R. O'Boyle, 2nd, J.H. Sun, R.A. Fridell, J.A. Lemm, M. Gao, A.C. Good, N.A. Meanwell, and L.B. Snyder. Bioorganic & Medicinal Chemistry Letters, 2013. 23(3): p. 779-784; PMID[23273521].

[PubMed] OV_0201-021413.


9. Novel Anilinocoumarin Derivatives as Agents against Hepatitis C Virus by the Induction of IFN-Mediated Antiviral Responses. Peng, H.K., W.C. Chen, J.C. Lee, S.Y. Yang, C.C. Tzeng, Y.T. Lin, and S.C. Yang. Organic & Biomolecular Chemistry, 2013. [Epub ahead of print]; PMID[23377187].

[PubMed] OV_0201-021413.


10. HCV NS5A Inhibitors in Development. Suk-Fong Lok, A. Clinics in Liver Disease, 2013. 17(1): p. 111-121; PMID[23177287].

[PubMed] OV_0201-021413.


11. IFITM1 Is a Tight Junction Protein That Inhibits Hepatitis C Virus Entry. Wilkins, C., J. Woodward, D.T. Lau, A. Barnes, M. Joyce, N. McFarlane, J.A. McKeating, D.L. Tyrrell, and M. Gale, Jr. Hepatology, 2013. 57(2): p. 461-469; PMID[22996292].

[PubMed] OV_0201-021413.

HSV-1

12. Antiherpetic Potential of 6-Bromoindirubin-3'-acetoxime (BIO-acetoxime) in Human Oral Epithelial Cells. Hsu, M.J. and S.L. Hung. Archives of Virology, 2013. [Epub ahead of print]; PMID[23392633].

[PubMed] OV_0201-021413.


13. A Cationic Peptide, TAT-CD0, Inhibits Herpes Simplex Virus Type 1 Ocular Infection in Vivo. Jose, G.G., I.V. Larsen, J. Gauger, E. Carballo, R. Stern, R. Brummel, and C.R. Brandt. Investigative Ophthalmology & Visual Science, 2013. 54(2): p. 1070-1079; PMID[23341013].

[PubMed] OV_0201-021413.


14. A Novel Selective LSD1/KDM1A Inhibitor Epigenetically Blocks Herpes Simplex Virus Lytic Replication and Reactivation from Latency. Liang, Y., D. Quenelle, J.L. Vogel, C. Mascaro, A. Ortega, and T.M. Kristie. mBio, 2013. 4(1); PMID[23386436].

[PubMed] OV_0201-021413.

SIV

15. Effect of Combination Antiretroviral Therapy on Chinese Rhesus Macaques of SIV Infection. Ling, B., L.B. Rogers, A.M. Johnson, M. Piatak, J. Lifson, and R. Veazey. AIDS Research and Human Retroviruses, 2013. [Epub ahead of print]; PMID[23387294].

[PubMed] OV_0201-021413.

Citations from the ISI Web of Knowledge Listings for O.V.

16. Hepatitis C Virus Protease Inhibitors. Abdel-Magid, A.F. ACS Medicinal Chemistry Letters, 2012. 3(9): p. 699-700; ISI[000312416200005].

[WOS] OV_0201-021413.


17. Inhibition on Hepatitis B Virus in Vitro of Lectin from Musca domestica Pupa Via the Activation of NF-Kappa B. Cao, X.H., M.H. Zhou, S.X. Wang, C.L. Wang, L.H. Hou, Y.Q. Luo, and L.Y. Chen. Virus Research, 2012. 170(1-2): p. 53-58; ISI[000312692100006].

[WOS] OV_0201-021413.


18. Hydrazonoyl Halides as Precursors for Synthesis of Novel Bioactive Thiazole and Formazan Derivatives. Farghaly, T.A. and E.M.H. Abbas. Journal of Chemical Research, 2012(11): p. 660-664; ISI[000313095100013].

[WOS] OV_0201-021413.


19. Discovery of New Scaffolds for Rational Design of HCV NS5B Polymerase Inhibitors. Golub, A.G., K.R. Gurukumar, A. Basu, V.G. Bdzhola, Y. Bilokin, S.M. Yarmoluk, J.C. Lee, T.T. Talele, D.B. Nichols, and N. Kaushik-Basu. European Journal of Medicinal Chemistry, 2012. 58: p. 258-264; ISI[000312745100025].

[WOS] OV_0201-021413.


20. Chemo-enzymatic Synthesis and Biological Evaluation of 5,6-Disubstituted Benzimidazole Ribo- and 2 '-Deoxyribonucleosides. Konstantinova, I.D., O.M. Selezneva, I.V. Fateev, T.A. Balashova, S.K. Kotovskaya, Z.M. Baskakova, V.N. Charushin, A.V. Baranovsky, A.I. Miroshnikov, J. Balzarini, and I.A. Mikhailopulo. Synthesis-Stuttgart, 2013. 45(2): p. 272-280; ISI[000313362800019].

[WOS] OV_0201-021413.


21. RNA Aptamer-mediated Interference of HCV Replication by Targeting the CRE-5BSl3.2 Domain. Marton, S., C. Romero-Lopez, and A. Berzal-Herranz. Journal of Viral Hepatitis, 2013. 20(2): p. 103-112; ISI[000313492600004].

[WOS] OV_0201-021413.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024